104 related articles for article (PubMed ID: 8285833)
21. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
22. High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma.
Ingen-Housz-Oro S; Bachelez H; Verola O; Lebbé C; Marolleau JP; Hennequin C; Dubertret L; Morel P; Gisselbrecht C; Brice P
Bone Marrow Transplant; 2004 Mar; 33(6):629-34. PubMed ID: 14755323
[TBL] [Abstract][Full Text] [Related]
23. [Assessment of the significance of histological, immunohistochemical and clinical data in the diagnosis of lymphoproliferative skin diseases in conformance with a consensus by international experts].
Belousova IIe; Kazakov DV; Samtsov AV; Kempf W
Arkh Patol; 2004; 66(2):11-6. PubMed ID: 15154375
[TBL] [Abstract][Full Text] [Related]
24. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
26. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
[TBL] [Abstract][Full Text] [Related]
28. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
29. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
30. Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients.
Willemze R; Meijer CJ; Scheffer E; Kluin PM; Van Vloten WA; Toonstra J; Van der Putte SC
Am J Pathol; 1987 Feb; 126(2):325-33. PubMed ID: 3548403
[TBL] [Abstract][Full Text] [Related]
31. [Cutaneous B cell lymphoma in chronic Borrelia burgdorferi infection. Report of 2 cases and a review of the literature].
Garbe C; Stein H; Gollnick H; Taud W; Orfanos CE
Hautarzt; 1988 Nov; 39(11):717-26. PubMed ID: 3072322
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
[TBL] [Abstract][Full Text] [Related]
33. Large B-cell lymphomas poor in B cells and rich in PD-1+ T cells can mimic T-cell lymphomas.
Ohgami RS; Zhao S; Natkunam Y
Am J Clin Pathol; 2014 Aug; 142(2):150-6. PubMed ID: 25015854
[TBL] [Abstract][Full Text] [Related]
34. [Systemic proliferative angioendotheliomatosis: a cutaneous manifestation of malignant B-cell lymphomas. Histologic and immunohistologic studies of two cases].
Kutzner H; Englert W; Hellenbroich D; Embacher G; Kutzner U; Schröder J
Hautarzt; 1991 Jun; 42(6):384-90. PubMed ID: 1917462
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous malignant lymphomas. A clinicopathologic study of thirty-seven cases.
Aozasa K; Inoue A; Yamamura T; Nishida K; Sano S
Acta Pathol Jpn; 1985 Sep; 35(5):1181-9. PubMed ID: 3936334
[TBL] [Abstract][Full Text] [Related]
36. Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas.
Beylot-Barry M; Sibaud V; Thiebaut R; Vergier B; Beylot C; Delaunay M; Chene G; Dubus P; Merlio JP
J Invest Dermatol; 2001 Oct; 117(4):920-6. PubMed ID: 11676833
[TBL] [Abstract][Full Text] [Related]
37. Immunological phenotypes of twelve cases of nonepidermotropic cutaneous T-cell lymphoma.
Ding TG; Luo JM; Zhang TM
Chin Med J (Engl); 1990 Mar; 103(3):223-7. PubMed ID: 2114964
[TBL] [Abstract][Full Text] [Related]
38. The histopathologic classification of cutaneous lymphomas.
Garvin AJ
Dermatol Clin; 1985 Oct; 3(4):587-91. PubMed ID: 2878752
[TBL] [Abstract][Full Text] [Related]
39. Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas.
Burg G; Schmid MH; Küng E; Dommann S; Dummer R
Dermatol Clin; 1994 Apr; 12(2):399-407. PubMed ID: 8045051
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous T-cell-rich B-cell lymphoma in a horse.
Hermeyer K; Seehusen F; Gehlen H; Peters M; Wohlsein P
Berl Munch Tierarztl Wochenschr; 2010; 123(9-10):422-4. PubMed ID: 21038813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
